In controlled experimental environments, investigators study its receptor-binding properties, intracellular signaling, and effects on metabolism-related gene expression
Ask about alternatives (e.g., tirzepatide, liraglutide, phentermine/topiramate) and how they fit your goals and health history
Eli Lilly, the manufacturer of the GLP-1 / GIP agonist tirzepatide (Mounjaro, Zepbound) has announced the development of bimagrumab (LY3985863), an injected monoclonal antibody that binds the activin/myostatin type II receptors ActRIIA and ActRIIB and blocks ligand binding
WARNING: If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use
Any stack involving multiple experimental compounds increases the unknowns around safety and interactions
They show varying degrees of effectiveness in blood glucose control and weight loss